Stuttgart - Delayed Quote EUR

Northwest Biotherapeutics, Inc. (NBYB.SG)

Compare
0.2480
-0.0140
(-5.34%)
At close: January 30 at 9:27:58 PM GMT+1

Research Analysis

Revenue vs. Earnings

Revenue 71k
Earnings -30.71M
Q1'16
Q2'16
Q3'16
Q4'16
-30M
-20M
-10M
0
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jan 1970)Current Year (1970)Next Year (1970)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jan 1970)Current Year (1970)Next Year (1970)
No. of Analysts --------
Avg. Estimate --------
Low Estimate --------
High Estimate --------
Year Ago Sales --------
Sales Growth (year/est) --------

EPS Trend

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jan 1970)Current Year (1970)Next Year (1970)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jan 1970)Current Year (1970)Next Year (1970)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
NBYB.SG --------
S&P 500 9.01%10.57%14.00%13.70%

Upgrades & Downgrades

Downgrade Oppenheimer: Outperform to Perform 3/12/2014

Related Tickers